Literature DB >> 30459172

Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.

Ashra Kolhatkar1, Lucy Cheng1, Steven G Morgan1, Laurie J Goldsmith1, Irfan A Dhalla1, Anne M Holbrook1, Michael R Law2.   

Abstract

BACKGROUND: Out-of-pocket drug costs lead many Canadians to engage in cost-related nonadherence to prescription medications, but our understanding of other consequences such as borrowing money remains incomplete. In this descriptive study, we sought to quantify the frequency of borrowing to pay for prescription drugs in Canada and characteristics of Canadians who borrowed money for this purpose.
METHODS: In partnership with Statistics Canada, we designed and administered a cross-sectional rapid-response module in the Canadian Community Health Survey administered by telephone to Canadians aged 12 years or more between January and June 2016. We restricted our analyses to participants who responded to the question regarding borrowing money to pay for prescription drugs and used logistic regression to identify characteristics associated with borrowing.
RESULTS: A total of 28 091 Canadians responded to the survey (overall response rate 61.8%). The weighted proportion of respondents who reported having borrowed money to pay for prescription drugs in the previous year was 2.5% (95% confidence interval 2.2%-2.8%), an estimated 731 000 Canadians. The odds of borrowing were higher among younger adults, people in poor health and people lacking prescription drug insurance. Other factors associated with increased adjusted odds of borrowing were having 2 or more chronic conditions, low household income and higher out-of-pocket prescription drug costs.
INTERPRETATION: Many Canadians reported borrowing money to pay for out-of-pocket prescription drug costs, and borrowing was more prevalent among already vulnerable groups that also report other compensatory behaviours to address challenges in paying for prescription drugs. Future research should investigate policy responses intended to increase equity in access to prescription drugs. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 30459172      PMCID: PMC6276978          DOI: 10.9778/cmajo.20180063

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  29 in total

1.  Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.

Authors:  Stephen B Soumerai; Marsha Pierre-Jacques; Fang Zhang; Dennis Ross-Degnan; Alyce S Adams; Jerry Gurwitz; Gerald Adler; Dana Gelb Safran
Journal:  Arch Intern Med       Date:  2006-09-25

2.  Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Authors:  Jeanne M Madden; Amy J Graves; Fang Zhang; Alyce S Adams; Becky A Briesacher; Dennis Ross-Degnan; Jerry H Gurwitz; Marsha Pierre-Jacques; Dana Gelb Safran; Gerald S Adler; Stephen B Soumerai
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

3.  The role of patient-physician trust in moderating medication nonadherence due to cost pressures.

Authors:  John D Piette; Michele Heisler; Sarah Krein; Eve A Kerr
Journal:  Arch Intern Med       Date:  2005 Aug 8-22

4.  Physician strategies to reduce patients' out-of-pocket prescription costs.

Authors:  G Caleb Alexander; Lawrence P Casalino; David O Meltzer
Journal:  Arch Intern Med       Date:  2005-03-28

Review 5.  Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.

Authors:  C Evans; B Crawford
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

6.  Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications?

Authors:  Michele Heisler; Todd H Wagner; John D Piette
Journal:  J Behav Med       Date:  2005-02

7.  A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.

Authors:  Jae Kennedy; Steve Morgan
Journal:  Clin Ther       Date:  2006-08       Impact factor: 3.393

8.  Barriers to patient-physician communication about out-of-pocket costs.

Authors:  G Caleb Alexander; Lawrence P Casalino; Chien-Wen Tseng; Diane McFadden; David O Meltzer
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

9.  Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.

Authors:  Jae Kennedy; Iulia Tuleu; Katherine Mackay
Journal:  J Manag Care Pharm       Date:  2008 Jul-Aug

Review 10.  Patients at-risk for cost-related medication nonadherence: a review of the literature.

Authors:  Becky A Briesacher; Jerry H Gurwitz; Stephen B Soumerai
Journal:  J Gen Intern Med       Date:  2007-04-05       Impact factor: 5.128

View more
  2 in total

1.  Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study.

Authors:  Stephanie Y Cheng; Farah E Saxena; Soo Jin Seung; Craig C Earle; Kelvin Chan; Nicole Mittmann
Journal:  CMAJ Open       Date:  2019-08-20

2.  The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.

Authors:  Nicole Atkins; Karim Mukhida
Journal:  Can J Pain       Date:  2022-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.